INFUSYSTEM HOLDINGS, INC Proceeds from (Repayments of) Debt
INFUSYSTEM HOLDINGS, INC (INFU) reported Proceeds from (Repayments of) Debt of $28.32 million for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-13.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepaymentsOfDebt · last filed 2017-11-13
- INFUSYSTEM HOLDINGS, INC proceeds from (repayments of) debt for the quarter ending 2017-09-30 was $9.21M, a 27.76% decline year-over-year.
- INFUSYSTEM HOLDINGS, INC proceeds from (repayments of) debt for the quarter ending 2017-06-30 was $15.01M, a 3.15% decline year-over-year.
- INFUSYSTEM HOLDINGS, INC proceeds from (repayments of) debt for the quarter ending 2017-03-31 was $4.10M, a 76.00% decline year-over-year.
- INFUSYSTEM HOLDINGS, INC proceeds from (repayments of) debt for the quarter ending 2016-12-31 was $21.57M, a 119.51% increase year-over-year.
- INFUSYSTEM HOLDINGS, INC proceeds from (repayments of) debt for fiscal 2016 was $66.89M, a 5.02% decline from fiscal 2015.
- INFUSYSTEM HOLDINGS, INC proceeds from (repayments of) debt for fiscal 2015 was $70.43M, a 13.87% increase from fiscal 2014.
- INFUSYSTEM HOLDINGS, INC proceeds from (repayments of) debt for fiscal 2014 was $61.85M, a 71.03% increase from fiscal 2013.
- INFUSYSTEM HOLDINGS, INC proceeds from (repayments of) debt for fiscal 2013 was $36.17M, a 2.52% decline from fiscal 2012.
| Period end | Proceeds from (Repayments of) Debt 3 month | Proceeds from (Repayments of) Debt 6 month | Proceeds from (Repayments of) Debt 9 month | Proceeds from (Repayments of) Debt 12 month | Proceeds from (Repayments of) Debt 12 month as first filed |
|---|---|---|---|---|---|
| 2017-09-30 | $9.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | $24.22M derived: sum of 2 quarters · filed 2017-11-13 | $28.32M 10-Q · filed 2017-11-13 | $49.88M derived: sum of 4 quarters · filed 2017-11-13 | |
| 2017-06-30 | $15.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $19.11M 10-Q · filed 2017-08-09 | $40.67M derived: sum of 3 quarters · filed 2017-08-09 | $53.42M derived: sum of 4 quarters · filed 2017-11-13 | |
| 2017-03-31 | $4.10M 10-Q · filed 2017-05-15 | $25.66M derived: sum of 2 quarters · filed 2017-05-15 | $38.42M derived: sum of 3 quarters · filed 2017-11-13 | $53.91M derived: sum of 4 quarters · filed 2017-11-13 | |
| 2016-12-31 | $21.57M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-22 | $34.32M derived: sum of 2 quarters · filed 2017-11-13 | $49.81M derived: sum of 3 quarters · filed 2017-11-13 | $66.89M 10-K · filed 2017-03-22 | |
| 2016-09-30 | $12.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | $28.25M derived: sum of 2 quarters · filed 2017-11-13 | $45.33M 10-Q · filed 2017-11-13 | $55.15M derived: sum of 4 quarters · filed 2017-11-13 | |
| 2016-06-30 | $15.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $32.58M 10-Q · filed 2017-08-09 | $42.40M derived: sum of 3 quarters · filed 2017-08-09 | $51.46M derived: sum of 4 quarters · filed 2017-08-09 | |
| 2016-03-31 | $17.08M 10-Q · filed 2017-05-15 | $26.91M derived: sum of 2 quarters · filed 2017-05-15 | $35.96M derived: sum of 3 quarters · filed 2017-05-15 | $41.53M derived: sum of 4 quarters · filed 2017-05-15 | |
| 2015-12-31 | $9.82M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-22 | $18.88M derived: sum of 2 quarters · filed 2017-03-22 | $24.45M derived: sum of 3 quarters · filed 2017-03-22 | $70.43M 10-K · filed 2017-03-22 | |
| 2015-09-30 | $9.06M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2016-12-12 | $14.63M derived: sum of 2 quarters · filed 2016-12-12 | $60.60M 10-Q · filed 2016-12-12 | $74.64M derived: sum of 4 quarters · filed 2016-12-12 | |
| 2015-06-30 | $5.57M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2016-12-12 | $51.55M 10-Q/A · filed 2016-12-12 | $65.58M derived: sum of 3 quarters · filed 2016-12-12 | $81.20M derived: sum of 4 quarters · filed 2016-12-12 | |
| 2015-03-31 | $45.98M 10-Q/A · filed 2016-12-12 | $60.02M derived: sum of 2 quarters · filed 2016-12-12 | $75.64M derived: sum of 3 quarters · filed 2016-12-12 | $93.57M derived: sum of 4 quarters · filed 2016-12-12 | |
| 2014-12-31 | $14.04M derived: 10-K/A 12 month − 10-Q 9 month · filed 2016-12-12 | $29.66M derived: sum of 2 quarters · filed 2016-12-12 | $47.59M derived: sum of 3 quarters · filed 2016-12-12 | $61.85M 10-K/A · filed 2016-12-12 | |
| 2014-09-30 | $15.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $33.55M derived: sum of 2 quarters · filed 2015-11-12 | $47.81M 10-Q · filed 2015-11-12 | $61.59M derived: sum of 4 quarters · filed 2015-11-12 | |
| 2014-06-30 | $17.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $32.20M 10-Q · filed 2015-08-13 | $45.97M derived: sum of 3 quarters · filed 2015-08-13 | $55.02M derived: sum of 4 quarters · filed 2015-08-13 | |
| 2014-03-31 | $14.26M 10-Q · filed 2015-05-12 | $28.03M derived: sum of 2 quarters · filed 2015-05-12 | $37.09M derived: sum of 3 quarters · filed 2015-05-12 | ||
| 2013-12-31 | $13.77M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-09 | $22.83M derived: sum of 2 quarters · filed 2015-03-09 | $36.17M 10-K · filed 2015-03-09 | ||
| 2013-09-30 | $9.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $22.39M 10-Q · filed 2014-11-10 | |||
| 2013-06-30 | $13.34M 10-Q · filed 2014-08-01 | ||||
| 2012-12-31 | $34.60M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-11 | $34.60M derived: sum of 2 quarters · filed 2014-03-11 | $34.60M derived: sum of 3 quarters · filed 2014-03-11 | $37.10M 10-K · filed 2014-03-11 | |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $0.00 derived: sum of 2 quarters · filed 2013-11-12 | $2.50M 10-Q · filed 2013-11-12 | $4.28M derived: sum of 4 quarters · filed 2013-11-12 | |
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-13 | $2.50M 10-Q · filed 2013-08-13 | $4.28M derived: sum of 3 quarters · filed 2013-08-13 | ||
| 2012-03-31 | $2.50M 10-Q · filed 2013-05-13 | $4.28M derived: sum of 2 quarters · filed 2013-05-13 | |||
| 2011-12-31 | $1.78M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | $2.33M 10-K · filed 2013-03-28 | $584.00K 10-K · filed 2012-03-16 | ||
| 2011-09-30 | $551.00K 10-Q · filed 2012-11-14 | ||||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-16 | $0.00 derived: sum of 2 quarters · filed 2012-03-16 | $30.00M 10-K · filed 2012-03-16 | ||
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $30.00M 10-Q · filed 2011-11-14 | |||
| 2010-06-30 | $30.00M 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |